Avantor (AVTR) Receives a Buy from Barclays

Barclays analyst Luke Sergott maintained a Buy rating on Avantor (AVTRResearch Report) on September 9 and set a price target of $30.00. The company’s shares closed last Friday at $25.83.

According to TipRanks, Sergott is a 3-star analyst with an average return of 1.7% and a 38.27% success rate. Sergott covers the Healthcare sector, focusing on stocks such as Icon, Thermo Fisher, and IQVIA Holdings.

Currently, the analyst consensus on Avantor is a Moderate Buy with an average price target of $35.40.

See the top stocks recommended by analysts >>

Based on Avantor’s latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of $1.91 billion and a net profit of $187.4 million. In comparison, last year the company earned a revenue of $1.86 billion and had a net profit of $157.8 million

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Avantor, Inc. is a provider of mission critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. It sells materials & consumables, equipment & instrumentation and services & specialty procurement. It operates in more than 30 countries and deliver an extensive portfolio of products and services. The company was founded by John Townsend Baker in 1904 and is headquartered in Radnor, PA.

Read More on AVTR:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More